- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02639390
Robotic Training for Stroke Neurorehabilitation
December 23, 2020 updated by: VA Office of Research and Development
Task-Specific Upper-Extremity Robotic Training for Stroke Neurorehabilitation
The overall goal is to further develop a robotic exoskeleton for neurorehabilitation of arm function after stroke.
The investigators previously developed a novel training protocol that combined the ARMin and HandSOME exoskeletons.
This is one of only a few arm exoskeletons that allow coordinated whole limb training in reach and grasp tasks with both virtual and real objects.
However, the robot has a very large inertia and friction, and only gross grasp patterns are available.
In development work, the investigators will significantly modify the AMRin and HandSOME to deliver a state-of-the-art lightweight robotic exoskeleton capable of retraining a wide range of functional activities.
In the subsequent testing phase, a clinical trial will examine the effects of robotic training in chronic stroke subjects.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
In a pilot clinical trial, the investigators found that the current robotic exoskeleton elicited improvements in arm function that can potentially supplement conventional methods to improve outcomes.
However, the robot has a very large inertia and friction, and only gross grasp patterns are available.
Therefore, improvements in movement speed and fine grasp were limited after robotic training.
In development work, the investigators will significantly modify the ARMin and HandSOME to deliver a state-of-the-art lightweight robotic exoskeleton capable of retraining a wide range of functional activities.
The investigators will reduce the inertia and friction of the robot to 1/4 of current values, incorporate an adaptive algorithm to automatically adjust assistance levels and extend the range of grasp patterns to include power grasp, thumb-index finger pinch and key pinch.
Using the improved device from the development activities, the investigators will perform a clinical trial to compare the effectiveness of robotic training to conventional therapy from an occupational therapist.
To take advantage of the facilitatory effect of robot therapy on subsequent conventional therapy, the experimental treatment will be 12 hours of robot therapy followed by 12 hours of conventional therapy.
Chronic stroke subjects (N=38) will be randomly assigned to receive this experimental treatment or 24 hours of conventional therapy from an occupational therapist.
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20422
- Washington DC VA Medical Center, Washington, DC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 21 or older
- Ischemic or hemorrhagic stroke (with confirmatory neuroimaging) that occurred more than 6 months before entering the study
- Presence of voluntary hand activity indicated by a score of at least 1 on the finger mass extension/grasp release item of the Fugl-Meyer Test of Motor Function
- Adequate cognitive status, as determined by clinical evaluation
- No upper extremity injury or conditions that limited use prior to the stroke
Exclusion Criteria:
- Cannot give informed consent
- Have clinically significant fluctuations in mental status within a month of enrollment
- Were not independent prior to the stroke as measured by scores <95 on the Barthel Index or >1 on the Modified Rankin Scale
- Have hemispatial neglect as determined by >3 errors on the Star Cancellation Test
- Have severe sensory loss as determined by a score of 2 on the sensory item of the NIHSS
- Receiving oral or injected antispasticity medications during study treatment
- Pain that interferes with daily activities
- History of prior stroke
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Robotic
The experimental group will receive 1-hour robotic training sessions, 3 times per week for a total of 12 sessions supervised by a research assistant.
Immediately following this robot training, these subjects will receive the same dosage and schedule (1-hour sessions, 3 times/week, 12 total sessions) of conventional one-on-one therapy from an occupational therapist.
|
Subjects will be placed in the robot and practice common upper extremity tasks involving grasping, manipulating and moving objects.
An occupational therapist will provide one-on-one individualized programs focused on arm function.
Treatment will focus on practice of specific tasks, such as reach, grasp, transport and release of various objects between different targets.
Progression is done by varying the shape, size and weight of objects, altering the end range of the target or increasing the speed of movement.
|
Active Comparator: Conventional
Subjects will receive 24 hours of one-on-one treatment from an occupational therapist.
The treatment schedule will parallel that given to the experimental group (1-hour sessions, 3 times/week).
|
An occupational therapist will provide one-on-one individualized programs focused on arm function.
Treatment will focus on practice of specific tasks, such as reach, grasp, transport and release of various objects between different targets.
Progression is done by varying the shape, size and weight of objects, altering the end range of the target or increasing the speed of movement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Fugl-Meyer Score
Time Frame: Change from baseline to 8 weeks
|
The Fugl-Meyer Test of Motor Function will be used to assess motor impairments at the shoulder, elbow, wrist and fingers.
The Fugl-Meyer test scores reflexes and the ability to perform several movements and tasks on a 3-point scale.
The Fugl-Meyer was designed for the recovery patterns observed after stroke and is very responsive to change in severe and moderately impaired subjects.
|
Change from baseline to 8 weeks
|
Change in Action Research Arm Test
Time Frame: Change from baseline to 8 weeks
|
The Action Research Arm Test (ARAT) is an impairment level measurement tool that assesses the functional limitations of the upper extremities.
It is one of the most frequently used primary endpoints in upper extremity (UE) training trials in stroke.
The assessment incorporates 19 items that are divided into four subscales: Grasp, Grip, Pinch, and Gross movement.
Item scores are summed to form a subtest score, and then a full-scale score.
|
Change from baseline to 8 weeks
|
Change in Motor Activity Log
Time Frame: Change from baseline to 8 weeks
|
The Motor Activity Log (MAL) will be used to assess use of the limb at home.
It is a structured interview during which respondents are asked to rate how they use their more-impaired arm for 28 activities of daily living (ADL) in the home over a specified period.
Activities include brushing teeth, buttoning a shirt or blouse, and eating with a fork or spoon.
|
Change from baseline to 8 weeks
|
Change in Fugl-Meyer Score at Follow-up
Time Frame: Change from baseline to 8 months
|
The Fugl-Meyer Test of Motor Function will be used to assess motor impairments at the shoulder, elbow, wrist and fingers.
The Fugl-Meyer test scores reflexes and the ability to perform several movements and tasks on a 3-point scale.
The Fugl-Meyer was designed for the recovery patterns observed after stroke and is very responsive to change in severe and moderately impaired subjects.
|
Change from baseline to 8 months
|
Change in Action Research Arm Test at Follow-up
Time Frame: Change from baseline to 8 months
|
The Action Research Arm Test (ARAT) is an impairment level measurement tool that assesses the functional limitations of the upper extremities.
It is one of the most frequently used primary endpoints in upper extremity (UE) training trials in stroke.
The assessment incorporates 19 items that are divided into four subscales: Grasp, Grip, Pinch, and Gross movement.
Item scores are summed to form a subtest score, and then a full-scale score.
|
Change from baseline to 8 months
|
Change in Motor Activity Log at Follow-up
Time Frame: Change from baseline to 8 months
|
The Motor Activity Log (MAL) will be used to assess use of the limb at home.
It is a structured interview during which respondents are asked to rate how they use their more-impaired arm for 28 activities of daily living (ADL) in the home over a specified period.
Activities include brushing teeth, buttoning a shirt or blouse, and eating with a fork or spoon.
|
Change from baseline to 8 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Peter S. Lum, PhD, Washington DC VA Medical Center, Washington, DC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 7, 2018
Primary Completion (Actual)
December 31, 2019
Study Completion (Actual)
December 31, 2019
Study Registration Dates
First Submitted
December 15, 2015
First Submitted That Met QC Criteria
December 21, 2015
First Posted (Estimate)
December 24, 2015
Study Record Updates
Last Update Posted (Actual)
January 13, 2021
Last Update Submitted That Met QC Criteria
December 23, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A1966-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Robotic Therapy
-
Istanbul Physical Medicine Rehabilitation Training...Completedthe Effect of Virtual Reality on Stroke Rehabilitation
-
University of Sao Paulo General HospitalUnknown
-
Fondazione Don Carlo Gnocchi OnlusCompleted
-
University of Sao Paulo General HospitalUnknown
-
US Department of Veterans AffairsCompleted
-
University of Wisconsin, MadisonNational Center for Advancing Translational Sciences (NCATS)Terminated
-
Sahel Taravati, M.D.CompletedHemiplegia and/or Hemiparesis Following StrokeTurkey
-
I.R.C.C.S. Fondazione Santa LuciaCampus Bio-Medico UniversityCompletedStroke | Paresis | Upper Extremity ParalysisItaly
-
Chang Gung Memorial HospitalCompletedChronic StrokeTaiwan
-
Cliniques universitaires Saint-Luc- Université...Completed